Population-Adjusted Indirect Treatment Comparison with the outstandR Package in R
Nathan Green

TL;DR
This paper introduces outstandR, an R package that offers a comprehensive, unified framework for population-adjusted indirect treatment comparisons, integrating advanced methods to improve evidence synthesis in health technology assessments.
Contribution
The paper presents outstandR, an R package that consolidates various population-adjusted indirect comparison methods, including G-computation and MIM, into a flexible, user-friendly tool for HTA applications.
Findings
outstandR enables robust covariate adjustment in indirect comparisons
The package integrates Bayesian and maximum likelihood G-computation methods
It streamlines workflows for complex evidence synthesis
Abstract
Indirect treatment comparisons (ITCs) are essential in Health Technology Assessment (HTA) when head-to-head clinical trials are absent. A common challenge arises when attempting to compare a treatment with available individual patient data (IPD) against a competitor with only reported aggregate-level data (ALD), particularly when trial populations differ in effect modifiers. While methods such as Matching-Adjusted Indirect Comparison (MAIC) and Simulated Treatment Comparison (STC) exist to adjust for these cross-trial differences, software implementations have often been fragmented or limited in scope. This article introduces outstandR, an R package designed to provide a comprehensive and unified framework for population-adjusted indirect comparison (PAIC). Beyond standard weighting and regression approaches, outstandR implements advanced G-computation methods within both maximum…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Statistical Methods in Clinical Trials · Health Systems, Economic Evaluations, Quality of Life
